Opinions expressed by Entrepreneur contributors are their own.
Key Takeaways British footballer David Beckham came out with supplement brand IM8 in November 2024.
Since launch, the brand has achieved $120 million in ARR within the first year and does $10 million in monthly revenue.
Much of the credit for the brand’s growth goes to Beckham’s cofounder, Danny Yeung.
It’s probably no shocker that when “Golden Balls” David Beckham came out with a supplement brand in November, 2024, it took off. The British footballer has north of 88 million followers on Instagram, not to mention a household name.
But $120 million in ARR within the first year? $10 million in monthly revenue? The No. 1 world female tennis player, Aryna Sabalenka, as an ambassador? There’s clearly something else going on. No matter who you are, cutting through the thick traffic of the supplement market, jammed with products and skepticism, is daunting. Not to mention all the supplements already backed by celebrity athletes—Tom Brady, Venus Williams, Lebron and Arnold (James and Schwarzenegger) to name a few. A lot of the credit goes to Beckham’s cofounder Danny Yeung.
When they first met in London via a mutual friend, on the face of it, the two had nothing in common. Yeung was founder of Prenetics, a Hong Kong Covid testing startup, and his biggest win in sports had been selling baseball cards at age 12. Beckham, of course, was Beckham. But they connected on the topic of supplements—Beckham because he was sick of taking so many pills every day and Yeung because he saw the potential for using science to stand out in an unregulated market filled with questionable products. They walked out of the meeting on the way to founding IM8.
David Beckham. Credit: IM8
“From the start, Danny and I shared in the frustration of an overly complicated supplement market,” says Beckham. “Our partnership is founded on a willingness to invest in time and resources to do this right, through clinical trials, scientific testing, and a world-class Scientific Advisory Board.”
Identify the weakness in the market
... continue reading